Head-to-head · Cost-Efficiency Index
Tablet Health vs ARSYNL Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Tablet Health
Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list.
Visit Tablet HealthARSYNL Rx
Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Visit ARSYNL RxThe verdict
Tablet Health takes it, leading the Cost-Efficiency Index 57 to 56. Tablet Health is a LegitScript-certified DTC telehealth platform selling compounded semaglutide and tirzepatide in both oral-tablet and injectable form, priced from $179/mo (oral semaglutide) to $299/mo (injectable tirzepatide). ARSYNL Rx still earns a C — Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Tablet Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Tablet Health | ARSYNL Rx |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 56/100 |
| Semaglutide / mo | $199/mo (compounded) | $233/mo (starting dose, compounded) |
| Tirzepatide / mo | $299/mo (compounded) | $233/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,796 |
| Tirzepatide / yr (modeled) | $3,588 | $2,796 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #315 | #320 |
Tablet Health
57/100Where the value is
- LegitScript Certified — seal displayed on the site
- Offers both oral-tablet and injectable forms of semaglutide AND tirzepatide, four distinct SKUs
- Published per-product pricing rather than a single vague 'starting at' figure: $179-$299/mo across the four variants
The tradeoffs
- States served are not published anywhere on the accessible site — eligibility is only revealed by completing the intake quiz
- The homepage's 'Flat monthly pricing starting at $149' banner cannot be tied to any of the four listed $179-$299 tiers
ARSYNL Rx
56/100Where the value is
- Genuinely veteran-founded — the About page names founder Arron Glysch and recounts his own hair-loss experience while deployed overseas
- Offers a needle-free tirzepatide HypoSpray with six published dose protocols (10mg-60mg total/month)
- All three GLP-1 SKUs are stated to already include the consultation and shipping in the quoted price
The tradeoffs
- No compounding pharmacy is named on any product page checked
- No individual medical director or prescriber is named anywhere accessible — only 'U.S. board certified physicians' as a category
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.